MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Phase 2

Completed

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma
Recurrent Adult Burkitt Lymphoma
Recurrent Adult Lymphoblastic Lymphoma
Recurrent Adult T-cell Leukemia/Lymphoma
Recurrent Adult Diffuse Large Cell Lymphoma
Recurrent Grade 3 Follicular Lymphoma
Splenic Marginal Zone Lymphoma
Waldenstrom Macroglobulinemia
Anaplastic Large Cell Lymphoma
Angioimmunoblastic T-cell Lymphoma

Interventions: Drug: panobinostat
Other: laboratory biomarker analysis
Genetic: western blotting
Genetic: DNA analysis
Other: flow cytometry
Other: pharmacological study
Other: immunohistochemistry staining method

First Posted Date: 2010-12-16

Last Posted Date: 2022-05-24

Lead Sponsor: Mayo Clinic

Target Recruit Count: 41

Registration Number: NCT01261247

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS)

Phase 2

Completed

Conditions: Irritable Bowel Syndrome

Interventions: Drug: Placebo
Drug: Dronabinol

First Posted Date: 2010-12-03

Last Posted Date: 2013-05-07

Lead Sponsor: Mayo Clinic

Target Recruit Count: 36

Registration Number: NCT01253408

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Exercise for Fibromyalgia

Not Applicable

Completed

Conditions: Fibromyalgia

Interventions: Behavioral: Strength training
Behavioral: Aerobic exercise

First Posted Date: 2010-12-03

Last Posted Date: 2010-12-03

Lead Sponsor: Mayo Clinic

Target Recruit Count: 72

Registration Number: NCT01253395

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Carbon-13 (13C)-Spirulina Platensis Gastric Emptying Breath Test (GEBT)

Not Applicable

Completed

Conditions: Dyspepsia

Interventions: Drug: [13C]-Spirulina platensis and 99mTc sulfur colloid

First Posted Date: 2010-11-25

Last Posted Date: 2013-03-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 30

Registration Number: NCT01248221

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Assessment of Combined Bowel Preparation for Capsule Endoscopy Study

Phase 1

Completed

Conditions: Gastrointestinal Hemorrhage

Interventions: Drug: Combination Prep

First Posted Date: 2010-11-18

Last Posted Date: 2016-01-20

Lead Sponsor: Mayo Clinic

Target Recruit Count: 50

Registration Number: NCT01243736

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Self Help Intervention to Decrease Stress

Not Applicable

Completed

Conditions: Stress, Psychological

Interventions: Behavioral: Attention and Interpretation Therapy

First Posted Date: 2010-11-17

Last Posted Date: 2013-04-26

Lead Sponsor: Mayo Clinic

Target Recruit Count: 33

Registration Number: NCT01242865

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Vitamin D Supplementation in Breastfeeding Women

Phase 2

Completed

Conditions: Rickets
Vitamin D Deficiency
Infant Nutrition Disorders

Interventions: Dietary Supplement: Vitamin D3

First Posted Date: 2010-11-15

Last Posted Date: 2013-04-30

Lead Sponsor: Mayo Clinic

Target Recruit Count: 80

Registration Number: NCT01240265

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin Resistance

Phase 1

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Human insulin

First Posted Date: 2010-11-15

Last Posted Date: 2013-06-05

Lead Sponsor: Mayo Clinic

Target Recruit Count: 14

Registration Number: NCT01240252

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Histology of Functional Density in Postmenopausal Breast

Completed

Conditions: Dense Breasts
Breast Cancer

First Posted Date: 2010-11-15

Last Posted Date: 2022-07-26

Lead Sponsor: Mayo Clinic

Target Recruit Count: 25

Registration Number: NCT01240278

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma

Early Phase 1

Completed

Conditions: Nodal Marginal Zone B-cell Lymphoma
Adult Immunoblastic Large Cell Lymphoma
Adult Lymphoblastic Lymphoma
Small Lymphocytic Lymphoma
Adult Diffuse Mixed Cell Lymphoma
Grade 1 Follicular Lymphoma
Grade 3 Follicular Lymphoma
Mantle Cell Lymphoma
Cutaneous B-cell Non-Hodgkin Lymphoma
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue

Interventions: Biological: dendritic cell vaccine therapy
Procedure: cryotherapy
Biological: pneumococcal polyvalent vaccine
Other: laboratory biomarker analysis
Other: immunoenzyme technique
Other: immunohistochemistry staining method
Biological: autologous dendritic cell-tumor fusion vaccine

First Posted Date: 2010-11-11

Last Posted Date: 2020-01-14

Lead Sponsor: Mayo Clinic

Target Recruit Count: 16

Registration Number: NCT01239875

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy